Literature DB >> 16179828

Cerebral amyloid angiopathy with severe secondary vascular pathology: a histopathological study.

Jack van Horssen1, Danielle de Jong, Robert M W de Waal, Cathy Maass, Irene Otte-Holler, Berry Kremer, Marcel M Verbeek, Pieter Wesseling.   

Abstract

Cerebral amyloid angiopathy (CAA) is a common neuropathological finding and is characterized by deposition of fibrillar amyloid in cortical and leptomeningeal vessels. In this study we describe the macroscopic and microscopic neuropathological findings of 5 patients with severe CAA-associated secondary vascular changes, including smooth muscle cell degeneration, hyalinization, 'double-barreling' phenomenon, macrophage infiltration, and aneurysmal dilatation of the vessel wall. In 3 of the 5 patients these vascular changes were associated with multiple small hemorrhages, whereas in 2 patients areas of ischemic necrosis were observed. However, none of these patients suffered from large (lobar) hemorrhagic accidents. Nevertheless, severe CAA, particularly when associated with secondary vascular pathology, may lead to vascular dementia-like ischemic changes. Hence, the distinction between patients with severe CAA and secondary vascular abnormalities from those suffering from vascular dementia can be difficult. We speculate that CAA, particularly when associated with secondary vascular pathology, although not resulting in large hemorrhages, may contribute to cognitive decline. The functional impact of CAA and CAA-related secondary vascular changes on cognitive performance warrants further exploration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179828     DOI: 10.1159/000088462

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  3 in total

Review 1.  Ischemic brain injury in cerebral amyloid angiopathy.

Authors:  Yael D Reijmer; Susanne J van Veluw; Steven M Greenberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

Review 2.  Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?

Authors:  T Michael De Silva; Alyson A Miller
Journal:  Front Pharmacol       Date:  2016-03-17       Impact factor: 5.810

3.  APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis.

Authors:  Kristiina Rannikmäe; Rajesh N Kalaria; Steven M Greenberg; Helena C Chui; Frederick A Schmitt; Neshika Samarasekera; Rustam Al-Shahi Salman; Cathie L M Sudlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-10-25       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.